![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
HCV TREATMENT IN PEOPLE WHO INJECT DRUGS CO-LOCATED
WITHIN A NEEDLE SYRINGE PROGRAM
|
|
|
Reported by Jules Levin
CROI 2017 Feb 14-17 Seattle, WA
Benjamin Eckhardt1, Kristen Marks1, Brian Edlin1,2 1Weill Cornell Medicine; 2National Development and Research Institute
![0321171](../images/032117/032117-1/0321171.gif)
![0321172](../images/032117/032117-1/0321172.gif)
![0321173](../images/032117/032117-1/0321173.gif)
![0321174](../images/032117/032117-1/0321174.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|